Over-expression of Flt3 induces NF-κB pathway and increases the expression of IL-6

被引:42
|
作者
Takahashi, S
Harigae, H
Ishii, KK
Inomata, M
Fujiwara, T
Yokoyama, H
Ishizawa, K
Kameoka, J
Licht, JD
Sasaki, T
Kaku, M
机构
[1] Tohoku Univ, Sch Med, Dept Clin Lab Med, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ, Sch Med, Dept Rheumatol & Hematol, Aoba Ku, Sendai, Miyagi 9808574, Japan
[3] Mt Sinai Sch Med, Dept Med, Div Hematol Oncol, New York, NY 10029 USA
基金
日本学术振兴会;
关键词
Flt3; Nf-kappa B; IL-6; AML;
D O I
10.1016/j.leukres.2005.01.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Activating mutations or over-expression of the Flt3 is prevalent in acute myeloblastic leukemia (AML), associated with activation of Ras/MAP kinase and other signaling pathways. In this study, we addressed the role of Flt3 in the activation of nuclear factor-kappa B (NF-kappa B); which is a target molecule of these kinase pathways. In BaF3 cells stably expressing 1710, a NF-kappa B-responsive reporter was upregulated and its target gene, IL-6, was increased by the involvement of Flt3-ERK/MAPK-NF-kappa B pathway. Furthermore, we found a modest positive correlation (r = 0.35, p = 0.096) between Flt3 and IL-6 mRNA expression in 24 AML specimens. These results suggest a role of Flt3 overexpression in NF-kappa B pathway. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:893 / 899
页数:7
相关论文
共 50 条
  • [21] Cooperation of NFκB and CREB to induce synergistic IL-6 expression in astrocytes
    Spooren, Anneleen
    Kooijman, Ron
    Lintermans, Beatrice
    Van Craenenbroeck, Kathleen
    Vermeulen, Linda
    Haegeman, Guy
    Gerlo, Sarah
    CELLULAR SIGNALLING, 2010, 22 (05) : 871 - 881
  • [22] Expression and significance of TLR4/NF-κB/IL-6 in murine colon tissue of ulcerative colitis
    Liu, Hai-Feng
    Xu, Yang
    Zhang, Cheng-Gang
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 703 - 703
  • [23] Cadmium-induced IL-6 and IL-8 expression and release from astrocytes are mediated by MAPK and NF-κB
    Phuagkhaopong, Suttinee
    Ospondpant, Dusadee
    Kasemsuk, Thitima
    Sibmooh, Nathawut
    Soodvilai, Sunhapas
    Power, Christopher
    Vivithanaporn, Pornpun
    NEUROTOXICOLOGY, 2017, 60 : 82 - 91
  • [24] Luteolin 8-C-β-fucopyranoside downregulates IL-6 expression by inhibiting MAPKs and the NF-κB signaling pathway in human monocytic cells
    Young Seoung Lee
    Man Sub Kim
    Dong Hun Lee
    Tae Ho Kwon
    Hyuk-Hwan Song
    Sei-Ryang Oh
    Do Young Yoon
    Pharmacological Reports, 2015, 67 : 581 - 587
  • [25] Luteolin 8-C-β-fucopyranoside downregulates IL-6 expression by inhibiting MAPKs and the NF-κB signaling pathway in human monocytic cells
    Lee, Young Seoung
    Kim, Man Sub
    Lee, Dong Hun
    Kwon, Tae Ho
    Song, Hyuk-Hwan
    Oh, Sei-Ryang
    Yoon, Do Young
    PHARMACOLOGICAL REPORTS, 2015, 67 (03) : 581 - 587
  • [26] FLT3 Inhibitor Treatment Increases FLT3 Expression That Exposes FLT3-ITD+ AML Blasts to Elimination By FLT3 CAR-T Cells
    Jetani, Hardikkumar
    Garcia-Cadenas, Irene
    Nerreter, Thomas
    Goetz, Ralph
    Sierra, Jorge
    Bonig, Halvard
    Sauer, Markus
    Einsele, Hermann
    Hudecek, Michael
    BLOOD, 2018, 132
  • [27] A Novel Mutational Mechanism Drives Over-Expression of Ligand-Independent FLT3 in a Murine Model of B-Precursor ALL
    Johnson, Radia
    Papp, Eniko
    Grandal, Ildiko
    Kowalski, Paul
    Wong, Peggy P. C.
    Danska, Jayne S.
    Guidos, Cynthia
    BLOOD, 2011, 118 (21) : 293 - 293
  • [28] Asiaticoside Increases Caspase-9 Activity in MCF-7 Cells and Inhibits TNF-α and IL-6 Expression in Nude Mouse Xenografts via the NF-κB Pathway
    Al-Saeedi, Fatma J.
    MOLECULES, 2023, 28 (05):
  • [29] Elevated IL-6 expression in CD4 T cells via PKCθ and NF-κB induces Th2 cytokine production
    Sofi, M. Hanief
    Li, Wei
    Kaplan, Mark H.
    Chang, Cheong-Hee
    MOLECULAR IMMUNOLOGY, 2009, 46 (07) : 1443 - 1450
  • [30] Ethanol-Induced Upregulation of IL-6 and IL-8 in Astrocytes is Mediated by the NF-κB Pathway
    Gupte, R.
    Shah, A.
    Kumar, S.
    Kumar, A.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2011, 6 : S31 - S32